or Try an Advanced Search...

    Technical Analysis for COEP - Coeptis Therapeutics Holdings, Inc

    Grade Last Price % Change Price Change
    F 0.28 -1.80% -0.01
    COEP closed down 1.8 percent on Monday, July 1, 2024, on 5 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical COEP trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    BB Squeeze Started Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Resistance Bearish -1.80%
    Narrow Range Bar Range Contraction -1.80%
    Gapped Up Strength -1.80%
    Spinning Top Other -0.77%
    Down 3 Days in a Row Weakness -0.77%
    Gapped Down Weakness -0.77%
    Older End-of-Day Signals for COEP ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    Down 2 % about 8 hours ago
    Down 1% about 8 hours ago
    Down 2 % 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    COEP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Cell Therapy

    Is COEP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering
    May 30 Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting
    May 8 Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024
    May 2 Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
    Apr 2 Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award
    Feb 26 Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK
    Feb 7 Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral Infections
    Jan 18 Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying
    Jan 4 Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024
    See more COEP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.7
    52 Week Low 0.2303
    Average Volume 556,066
    200-Day Moving Average 0.67
    50-Day Moving Average 0.32
    20-Day Moving Average 0.29
    10-Day Moving Average 0.30
    Average True Range 0.03
    RSI (14) 44.13
    ADX 22.2
    +DI 10.67
    -DI 23.01
    Chandelier Exit (Long, 3 ATRs) 0.25
    Chandelier Exit (Short, 3 ATRs) 0.32
    Upper Bollinger Bands 0.33
    Lower Bollinger Band 0.26
    Percent B (%b) 0.35
    BandWidth 23.88
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram 0.0
    Fundamentals Value
    Market Cap 9.68 Million
    Num Shares 34.1 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -0.47
    Price-to-Sales 45.68
    Price-to-Book 3.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.30
    Resistance 3 (R3) 0.30 0.29 0.30
    Resistance 2 (R2) 0.29 0.29 0.29 0.30
    Resistance 1 (R1) 0.29 0.29 0.29 0.29 0.30
    Pivot Point 0.28 0.28 0.28 0.28 0.28
    Support 1 (S1) 0.28 0.28 0.28 0.28 0.27
    Support 2 (S2) 0.27 0.27 0.27 0.27
    Support 3 (S3) 0.26 0.27 0.27
    Support 4 (S4) 0.26